ANTITUMOR COMBINATION COMPRISING OMBRABULIN AND CETUXIMAB ASSOCIATED WITH RADIOTHERAPY

摘要

The invention relates to a pharmaceutical combination comprising ombrabulin or AVE8062, which may be in base form or in the form of a pharmaceutically acceptable salt and cetuximab, for its use as an antitumor agent for patients also treated. by radiotherapy, in particular suffering from cancers and even more particularly with solid tumors.